THE ABILITY OF THE SERUM THYROTROPIN RECEPTOR ANTIBODY (TRAB) INDEX AND HLA STATUS TO PREDICT LONG-TERM REMISSION OF THYROTOXICOSIS FOLLOWING MEDICAL THERAPY FOR GRAVES-DISEASE

被引：40
|
作者：
WILSON, R
MCKILLOP, JH
HENDERSON, N
PEARSON, DW
THOMSON, JA
机构：
[1] GLASGOW ROYAL INFIRM,DEPT IMMUNOL,GLASGOW G31 2ER,SCOTLAND
[2] ABERDEEN ROYAL INFIRM,ABERDEEN AB9 2ZB,SCOTLAND
来源：
CLINICAL ENDOCRINOLOGY | 1986年 / 25卷 / 02期
关键词：
D O I：
10.1111/j.1365-2265.1986.tb01676.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 156
页数：6
相关论文
共 10 条
  • [1] METAANALYSIS EVALUATION OF THE IMPACT OF THYROTROPIN RECEPTOR ANTIBODIES ON LONG-TERM REMISSION AFTER MEDICAL THERAPY OF GRAVES-DISEASE
    FELDTRASMUSSEN, U
    SCHLEUSENER, H
    CARAYON, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01): : 98 - 102
  • [2] THE ABILITY OF A TSH RECEPTOR ANTIBODY (TSHAB) INDEX AND HLA DR3 STATUS TO PREDICT CASES OF SHORT AND LONG-TERM RELAPSE OF GRAVES-DISEASE FOLLOWING TREATMENT WITH ANTITHYROID DRUGS
    WILSON, R
    MCKILLOP, JH
    HENDERSON, N
    PEARSON, D
    THOMSON, JA
    [J]. SCOTTISH MEDICAL JOURNAL, 1986, 31 (01) : 56 - 56
  • [3] INCREASED ACTIVATED LYMPHOCYTES-T AND NORMAL THYROTROPIN RECEPTOR ANTIBODY-LEVELS IN GRAVES-DISEASE IN LONG-TERM REMISSION
    PEAKMAN, M
    HUSSAIN, M
    CUNDY, T
    VERGANI, D
    [J]. JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1989, 30 (01) : 1 - 5
  • [4] LONG-TERM EFFECTS OF RADIOIODINE ON THYROTROPIN RECEPTOR ANTIBODIES IN GRAVES-DISEASE
    AIZAWA, Y
    YOSHIDA, K
    KAISE, N
    KAISE, K
    FUKAZAWA, H
    KISO, Y
    MORI, K
    SAYAMA, N
    KIKUCHI, K
    ABE, K
    [J]. CLINICAL ENDOCRINOLOGY, 1995, 42 (05) : 517 - 522
  • [5] THE PREDICTION OF GRAVES-DISEASE FOLLOWING ANTITHYROID DRUG-THERAPY BY SERUM THYROTROPIN RECEPTOR ANTIBODIES (TRAB) AS ANALYZED BY RADIORECEPTOR ASSAY AND CAMP PRODUCTION
    WILSON, R
    FRASER, WD
    MCKILLOP, JH
    THOMSON, JA
    [J]. SCOTTISH MEDICAL JOURNAL, 1988, 33 (04) : 317 - 317
  • [6] SERUM THYROGLOBULIN CHANGES IN PATIENTS WITH GRAVES-DISEASE TREATED WITH LONG-TERM ANTI-THYROID DRUG-THERAPY
    KAWAMURA, S
    KISHINO, B
    TAJIMA, K
    MASHITA, K
    TARUI, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (03): : 507 - 512
  • [7] Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease
    Akuzawa, M
    Murakami, M
    Yamada, M
    Satoh, T
    Shimizu, H
    Mori, M
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (03) : 281 - 285
  • [8] Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves' Disease
    Okamura, Ken
    Bandai, Sachiko
    Fujikawa, Megumi
    Sato, Kaori
    Ikenoue, Hiroshi
    Kitazono, Takanari
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 18
  • [9] EVIDENCE OF A CORRELATION BETWEEN THYROTROPIN RECEPTOR-BINDING INHIBITION AND THYROID ADENYLATE-CYCLASE ACTIVATION BY IMMUNOGLOBULINS IN GRAVES-DISEASE BEFORE AND DURING LONG-TERM ANTITHYROID TREATMENT
    BLIDDAL, H
    BECH, K
    PETERSEN, PH
    SIERSBAEKNIELSEN, K
    FRIIS, T
    [J]. ACTA ENDOCRINOLOGICA, 1982, 101 (01): : 35 - 40
  • [10] RELAPSE OF GRAVES-DISEASE AFTER MEDICAL THERAPY - PREDICTIVE VALUE OF THYROIDAL TECHNETIUM-99M UPTAKE AND SERUM THYROID STIMULATING HORMONE RECEPTOR ANTIBODY-LEVELS
    WILSON, R
    MCKILLOP, JH
    PEARSON, DWM
    CUTHBERT, GF
    THOMSON, JA
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (09) : 1024 - 1028
1